Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Jul 12, 2016
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-07-09+29,988→ 60,012 totalExercise: $0.28From: 2016-07-09Exp: 2026-02-24→ Common Stock (29,988 underlying)
Footnotes (1)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 90,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 29,988 shares. The option had previously vested with respect to 30,024 shares.